Ligand Pharmaceuticals Incorporated
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2014
Total Assets: $258.0M
Liabilities Breakdown FY2014
Total Liabilities: $233.6M
Asset Breakdown
Total Assets: $258.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $160.2M | 62.1% |
| Accounts Receivable | $12.6M | 4.9% |
| Inventory | $269.0K | 0.1% |
| Property, Plant & Equipment | $486.0K | 0.2% |
| Goodwill | $12.2M | 4.7% |
| Intangible Assets | $50.7M | 19.7% |
| Other Assets | $21.5M | 8.3% |
Liabilities Breakdown
Total Liabilities: $233.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $7.7M | 3.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $225.9M | 96.7% |